Stay updated on Branebrutinib Safety & Efficacy in Autoimmune Diseases Clinical Trial
Sign up to get notified when there's something new on the Branebrutinib Safety & Efficacy in Autoimmune Diseases Clinical Trial page.

Latest updates to the Branebrutinib Safety & Efficacy in Autoimmune Diseases Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.3.3 was added and the HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed from the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedA new revision entry (v3.3.2) appears, replacing the previous revision (v3.3.1) in the Study Record History, with no changes to the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check41 days agoChange DetectedRevision history shows a new entry: v3.3.1 replacing v3.2.0 on the Study Record History page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page footer no longer displays the generic government funding status notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check63 days agoChange DetectedVersion 28 (submitted 2024-01-12) is now shown in the Record History. It includes updates to the Study Status and Contacts/Locations sections.SummaryDifference0.1%

- Check92 days agoChange Detected- Added a prominent notice about potential outages due to lapse in government funding and updated operating status guidance. - Updated version from v3.1.0 to v3.2.0.SummaryDifference10%

Stay in the know with updates to Branebrutinib Safety & Efficacy in Autoimmune Diseases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Branebrutinib Safety & Efficacy in Autoimmune Diseases Clinical Trial page.